Historically, the psychoanalytic community has rejected the use of psychotropic medication, on the basis of the belief that using medication to suppress symptoms such as depression and anxiety would obstruct access to psychic conflict and thereby impede the progress of analytic treatment.
However, it would appear that many psychoanalysts have reconsidered this point of view and are now combining medication with psychoanalytic treatment.
This paper reports the first systematic survey of medication use in psychoanalysis, Method : Forty-five training analysts were sent questionnaires that asked how many patients in analysis they had seen in the past 5 years and for details about any of those patients who had taken psychotropic medication.
The analysts reported that in the past 5 years, 51 (18%) of 277 patients in analysis were also taking psychotropic medication.
Most of these patients had been diagnosed with a unipolar mood disorder and were treated with some type of antidepressant.
In 84% of patients (36 of 43) with a unipolar mood disorder who had been treated with medication, the psychoanalyst judged that both the mood disorder and the analytic process improved.
The use of medication in combination with psychoanalysis is no longer an uncommon practice.
Analysts who prescribe medication find that, in general, the effect is to enhance rather than undermine the psychoanalytic process.
Mots-clés Pascal : Cure psychanalytique, Traitement associé, Chimiothérapie, Psychotrope, Enquête, Psychanalyste, Prescription médicale, Homme, Personnel sanitaire
Mots-clés Pascal anglais : Psychoanalytic cure, Combined treatment, Chemotherapy, Psychotropic, Inquiry, Psychoanalyst, Medical prescription, Human, Health staff
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0321436
Code Inist : 002B18I08. Création : 01/03/1996.